Ahmedabad-based Senores Pharmaceuticals Limited has received final approval from the Securities and Exchange Board of India (SEBI) to launch its initial public offering (IPO). The company, which filed its IPO papers in July 2024, has plans to raise up to Rs.500 crore through a mix of fresh equity issuance and an offer for sale (OFS) …